PHR Logo

Phreesia, Inc. (PHR) 

NYSE
Market Cap
$1.22B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
381 of 776
Rank in Industry
13 of 32

Largest Insider Buys in Sector

PHR Stock Price History Chart

PHR Stock Performance

About Phreesia, Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and …

Insider Activity of Phreesia, Inc.

Over the last 12 months, insiders at Phreesia, Inc. have bought $0 and sold $8.49M worth of Phreesia, Inc. stock.

On average, over the past 5 years, insiders at Phreesia, Inc. have bought $0 and sold $118.61M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Phreesia, Inc.

2024-10-18SaleSVP, Life Sciences
1,100
0.002%
$20.49$22,539-6.74%
2024-10-16SalePrincipal Accounting Officer
423
0.0007%
$21.33$9,023-11.37%
2024-10-15SaleChief Executive Officer
3,089
0.0051%
$21.03$64,947-12.08%
2024-10-15SaleChief Operating Officer
1,843
0.003%
$21.03$38,749-12.08%
2024-10-15SaleSVP, Life Sciences
2,011
0.0033%
$21.03$42,281-12.08%
2024-10-15SaleGeneral Counsel & Secretary
1,212
0.002%
$21.03$25,482-12.08%
2024-10-15SaleSVP, Human Resources
624
0.001%
$21.03$13,120-12.08%
2024-10-15SaleChief Financial Officer
864
0.0014%
$21.03$18,166-12.08%
2024-10-15SalePrincipal Accounting Officer
2,791
0.0046%
$20.92$58,395-12.08%
2024-09-19SaleSVP, Life Sciences
24
<0.0001%
$24.04$577-11.57%
2024-09-18SaleSVP, Life Sciences
61
0.0001%
$24.09$1,469-12.56%
2024-09-17SaleSVP, Life Sciences
36
<0.0001%
$24.77$892-13.85%
2024-09-12Saledirector
1,400
0.0023%
$23.03$32,239-10.10%
2024-09-11SaleGeneral Counsel & Secretary
2,072
0.0036%
$23.36$48,402+1.71%
2024-09-10SaleChief Executive Officer
5,295
0.0091%
$23.25$123,110-9.56%
2024-09-10SaleChief Operating Officer
3,148
0.0054%
$23.25$73,192-9.56%
2024-09-10SaleGeneral Counsel & Secretary
2,622
0.0045%
$23.25$60,962-9.56%
2024-09-10SaleSVP, Human Resources
737
0.0013%
$23.25$17,135-9.56%
2024-09-10SaleChief Financial Officer
3,502
0.006%
$23.25$81,422-9.56%
2024-09-10SalePrincipal Accounting Officer
744
0.0013%
$23.25$17,298-9.56%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fidelity Investments$183.93M13.397.69M-0.08%-$144,082.530.01
The Vanguard Group$109.31M7.964.57M-1.31%-$1.45M<0.01
Brown Advisory$100.88M7.354.22M+6.72%+$6.35M0.14
BlackRock$99.47M7.244.16M-2.23%-$2.27M<0.01
Capital International Investors$62.05M4.522.59M+221.08%+$42.73M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.